WO2002030959A3 - Peptides derives de smac (diablo) et procedes d'utilisation de ceux-ci - Google Patents
Peptides derives de smac (diablo) et procedes d'utilisation de ceux-ci Download PDFInfo
- Publication number
- WO2002030959A3 WO2002030959A3 PCT/US2001/032121 US0132121W WO0230959A3 WO 2002030959 A3 WO2002030959 A3 WO 2002030959A3 US 0132121 W US0132121 W US 0132121W WO 0230959 A3 WO0230959 A3 WO 0230959A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- diablo
- smac
- peptides derived
- methods
- use therefor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
L'invention concerne des peptides dérivés de la protéine humaine smac (DIABLO) de type sauvage qui se lie avec un membre de la famille des IAP (inhibitor of apoptosis proteins : protéines inhibant l'apoptose). Ces peptides peuvent être utilisés dans un procédé permettant l'identification de substances candidates induisant ou favorisant l'apoptose dans les cellules..
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68754900A | 2000-10-13 | 2000-10-13 | |
US09/687,549 | 2000-10-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002030959A2 WO2002030959A2 (fr) | 2002-04-18 |
WO2002030959A3 true WO2002030959A3 (fr) | 2002-09-26 |
Family
ID=24760847
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/032121 WO2002030959A2 (fr) | 2000-10-13 | 2001-10-12 | Peptides derives de smac (diablo) et procedes d'utilisation de ceux-ci |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2002030959A2 (fr) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001293189A1 (en) * | 2000-09-29 | 2002-04-08 | Trustees Of Princeton University | Compositions and methods for regulating apoptosis |
EP1519918A1 (fr) * | 2002-07-02 | 2005-04-06 | Novartis AG | Inhibiteurs peptidiques de la liaison de la proteine smac avec les proteines inhibitrices de l'apoptose (iap) |
AU2005218555B2 (en) | 2004-03-01 | 2008-01-03 | Board Of Regents, The University Of Texas System | Dimeric small molecule potentiators of apoptosis |
AU2005228950B2 (en) | 2004-03-23 | 2012-02-02 | Genentech, Inc. | Azabicyclo-octane inhibitors of IAP |
CA2570321C (fr) | 2004-07-02 | 2013-10-08 | Genentech, Inc. | Inhibiteurs de pai |
US7749520B2 (en) | 2004-07-07 | 2010-07-06 | Statens Serum Institut | Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids |
CA2574040C (fr) | 2004-07-15 | 2014-05-06 | Tetralogic Pharmaceuticals Corporation | Composes de liaison aux proteines iap |
EA019420B1 (ru) | 2004-12-20 | 2014-03-31 | Дженентех, Инк. | Пирролидиновые ингибиторы иап (ингибиторов апоптоза) |
CN103083644B (zh) | 2005-02-25 | 2014-05-28 | 泰特拉洛吉克药业公司 | Iap二聚体抑制剂 |
JP4954983B2 (ja) | 2005-05-18 | 2012-06-20 | ファーマサイエンス・インコーポレイテッド | Birドメイン結合化合物 |
KR20080067357A (ko) | 2005-10-25 | 2008-07-18 | 에게라 쎄라퓨틱스 인코포레이티드 | Iap bir 도메인 결합 화합물 |
US8247557B2 (en) | 2005-12-19 | 2012-08-21 | Genentech, Inc. | IAP inhibitors |
TWI504597B (zh) | 2006-03-16 | 2015-10-21 | Pharmascience Inc | 結合於細胞凋亡抑制蛋白(iap)之桿狀病毒iap重複序列(bir)區域之化合物 |
BRPI0711591A2 (pt) | 2006-05-16 | 2011-11-16 | Aegera Therapeutics Inc | composto de ligação de domìnio bir da iap |
JP5452223B2 (ja) | 2006-07-24 | 2014-03-26 | テトラロジック ファーマシューティカルズ コーポレーション | Iap阻害剤 |
US7985735B2 (en) | 2006-07-24 | 2011-07-26 | Tetralogic Pharmaceuticals Corporation | Dimeric IAP inhibitors |
CA2671607A1 (fr) | 2006-12-19 | 2008-07-03 | Genentech, Inc. | Inhibiteurs imidazopyridine de iap |
JP5368428B2 (ja) | 2007-04-30 | 2013-12-18 | ジェネンテック, インコーポレイテッド | Iapのインヒビター |
JP2011529962A (ja) | 2008-08-02 | 2011-12-15 | ジェネンテック, インコーポレイテッド | Iapのインヒビター |
US8283372B2 (en) | 2009-07-02 | 2012-10-09 | Tetralogic Pharmaceuticals Corp. | 2-(1H-indol-3-ylmethyl)-pyrrolidine dimer as a SMAC mimetic |
NZ602368A (en) | 2010-02-12 | 2014-10-31 | Pharmascience Inc | Iap bir domain binding compounds |
CN110713546B (zh) * | 2019-10-31 | 2021-04-20 | 中国医科大学附属第一医院 | 靶向survivin-XIAP复合物的抗肿瘤多肽Sur-X与用途 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999021015A2 (fr) * | 1997-10-21 | 1999-04-29 | Cranfield University | Ligands d'affinite, leur production, et leur utilisation |
WO2002016418A2 (fr) * | 2000-08-24 | 2002-02-28 | Thomas Jefferson University | Peptide ou polypeptide capable de liaison avec l'inhibiteur de la proteine de l'apoptose |
WO2002016402A2 (fr) * | 2000-08-23 | 2002-02-28 | Board Of Regents, The University Of Texas System | Composes apoptotiques |
WO2002026775A2 (fr) * | 2000-09-29 | 2002-04-04 | Trustees Of Princeton University | Compositions et methodes de regulation de l'apoptose |
-
2001
- 2001-10-12 WO PCT/US2001/032121 patent/WO2002030959A2/fr active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999021015A2 (fr) * | 1997-10-21 | 1999-04-29 | Cranfield University | Ligands d'affinite, leur production, et leur utilisation |
WO2002016402A2 (fr) * | 2000-08-23 | 2002-02-28 | Board Of Regents, The University Of Texas System | Composes apoptotiques |
WO2002016418A2 (fr) * | 2000-08-24 | 2002-02-28 | Thomas Jefferson University | Peptide ou polypeptide capable de liaison avec l'inhibiteur de la proteine de l'apoptose |
WO2002026775A2 (fr) * | 2000-09-29 | 2002-04-04 | Trustees Of Princeton University | Compositions et methodes de regulation de l'apoptose |
Non-Patent Citations (3)
Title |
---|
CHAI JIJIE ET AL: "STRUCTURAL AND BIOCHEMICAL BASIS OF APOPTOTIC ACTIVATION BY SMAC/DIABLO.", NATURE (LONDON), vol. 406, no. 6798, 2000, pages 855 - 862, XP002200489, ISSN: 0028-0836 * |
DU CHUNYING ET AL: "Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition", CELL, CELL PRESS, CAMBRIDGE, NA, US, vol. 102, no. 1, 7 July 2000 (2000-07-07), pages 33 - 42, XP002175396, ISSN: 0092-8674 * |
VERHAGEN ANNE M ET AL: "IDENTIFICATION OF DIABLO, A MAMMALIAN PROTEIN THAT PROMOTES APOPTOSIS BY BINDING TO AND ANTAGONIZING IAP PROTEINS", CELL, CELL PRESS, CAMBRIDGE, NA, US, vol. 102, 7 July 2000 (2000-07-07), pages 43 - 53, XP002175397, ISSN: 0092-8674 * |
Also Published As
Publication number | Publication date |
---|---|
WO2002030959A2 (fr) | 2002-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002030959A3 (fr) | Peptides derives de smac (diablo) et procedes d'utilisation de ceux-ci | |
WO2002032925A3 (fr) | Echafaudages proteiniques internes pour analogues d'anticorps et autres proteines de liaison | |
WO2003045310A3 (fr) | Dosage biologique numerique | |
AU2001286730A1 (en) | An iap binding peptide or polypeptide and methods of using the same | |
WO2002083921A8 (fr) | Acides nucleiques et proteines correspondantes utiles pour la detection et le traitement de divers cancers | |
WO2002020568A3 (fr) | Peptides mutants derives de bad et leur utilisation pour identifier des substances se liant a un element de la famille de proteines bcl-2 | |
AU2744200A (en) | Determining protein function and interaction from genome analysis | |
WO2002008767A3 (fr) | Nouveaux procedes et trousses de sequençage de polypeptides | |
WO2002066653A3 (fr) | Banques procaryotiques et leurs utilisations | |
AU2002219960A1 (en) | Molecules of the card-related protein family and uses thereof | |
WO2001057198A3 (fr) | Procedes de preparation | |
EP1136547A3 (fr) | Polypeptides Adamts, acides nucléiques codant pour ces polypeptides et leurs utilisations | |
WO2000075324A3 (fr) | Genes, proteines et matieres de recombinaison de type prion et procedes associes | |
WO2001056456A3 (fr) | Procedes et compositions permettant de detecter une maladie | |
AU2002214542A1 (en) | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | |
AU2002340881A1 (en) | Concentration of protein and/or peptides samples | |
WO2003010184A3 (fr) | Motif conserve d'interaction de xiap dans la caspase-9 et la proteine smac/diablo pour moduler l'apoptose | |
WO2002010417A3 (fr) | Procedes et compositions pour la construction et l'utilisation de virus a enveloppe comme particules de presentation | |
WO2005019825A3 (fr) | Especes polypeptidiques secretees et utilisation associee | |
AU2002365084A8 (en) | Method and reagent for the detection of proteins and peptides | |
WO2004094989A3 (fr) | Methodes d'analyse de proteines de cellule hote | |
EP1134286A3 (fr) | Adamts polypeptides, acides nucléiques les codant et leurs applications | |
WO2003100075A3 (fr) | Acides nucleiques et proteines bsnd | |
AU2001288363A1 (en) | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | |
WO2000057184A3 (fr) | Tests, methodes et moyens |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): CA JP MX |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): CA JP MX |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |